Product Description: Tinurilimab (Bay 1834942) is an anti-CEACAM6 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Eun Young Kim, et al. Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas. Transl Oncol. 2022 Jun;20:101402.